AzTrials
AzTrials

StrokeNCT04421937

The Effects of Neuromuscular Electrical Stimulation on Swallowing Functions in Stroke Patients With Dysphagia

A study testing Procedure: Traditional Dysphagia Therapy (TDT) and Procedure: Neuromuscular Electrical Stimulation with TDT in people with Stroke and Swallowing Disorder, run by Istanbul University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In our study, our aim is to evaluate the effect of neuromuscular electrical stimulation added to traditional dysphagia therapy in stroke patients with dysphagia, on functional oral intake status, dysphagia-related symptoms, quality of life, and complications related to dysphagia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Swallowing Disorder, Dysphagia
What is being tested?
Procedure: Traditional Dysphagia Therapy (TDT) and Procedure: Neuromuscular Electrical Stimulation with TDT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Apr 2020to 16 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • After the first week after a stroke, detecting dysphagia by using bedside water assessment test
  • Lesion location is shown by MRI or CT
  • Unsupported sitting balance
  • The score of Mini-mental state examination test (MMSE) 20 and above
  • Over 18 years old

Who cannot join

  • Global aphasia or cognitive disorders that may affect the understanding of the instructions
  • Patients with major medical problems that may affect participation
  • Tracheostomy presence
  • Previous neck surgery
  • To have received radiotherapy in the head or neck area
  • Presence of a cardiac pacemaker or a history of epilepsy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation

    Istanbul, Fatih, 34093

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of Neuromuscular Electrical Stimulation on Swallowing Functions in Stroke Patients With Dysphagia: Randomized Controlled Trial

In our study, our aim is to evaluate the effect of neuromuscular electrical stimulation added to traditional dysphagia therapy in stroke patients with dysphagia, on functional oral intake status, dysphagia-related symptoms, quality of life, and complications related to dysphagia.

Being tested
Procedure: Traditional Dysphagia Therapy (TDT), Procedure: Neuromuscular Electrical Stimulation with TDT
Keywords
stroke, swallowing disorder, dysphagia, stroke rehabilitation, neuromuscular electrical stimulation, traditional dysphagia therapy
Medical subject headings
Stroke, Deglutition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Procedure: Traditional Dysphagia Therapy (TDT)Behavioural

    Traditional dysphagia therapy includes diet modification training, teaching postural compensatory methods, training of oral motor control exercises and tongue root exercises, training of swallowing maneuvers, and practice of chin-resistance exercise, which is the exercise of opening the upper esophageal sphincter.

    Traditional Dysphagia Therapy will be applied for 45 minutes a day, 5 days a week for 3 weeks.

  • Procedure: Neuromuscular Electrical Stimulation with TDTDevice

    The skin to be treated will be cleaned and dried. NMES will be implemented with signals received from two channels. In the first channel, the upper electrodes will be placed horizontally just above the hyoid bone. This is the place where the cupping is felt when the finger is pressed right under the chin. In the second channel, the lower electrodes will be placed horizontally, just above the thyrohyoid muscle. This is the place where you can feel a cupping when pressed with your finger, on both sides of the apple in the larynx. The device will be set to start at the lowest power, with very short pulses of approximately 700 microseconds, at intervals of 1 second. The power will be gradually increased according to the device and the power that the patient feels vibration will be stopped. The power to be applied will not exceed 25 milliamps. NMES application and Traditional Dysphagia Therapy will be applied for 45 minutes a day, 5 days a week for 3 weeks.

Study groups in NCT04421937
Study groupRoleWhat they receive
Neuromuscular Electrical Stimulation (NMES) with TDTExperimentalNot described
Receives: Device: Procedure: Neuromuscular Electrical Stimulation with TDT
Traditional Dysphagia Therapy (TDT)Active comparatorNot described
Receives: Behavioral: Procedure: Traditional Dysphagia Therapy (TDT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Functional Oral Intake Scale (FOIS)

    Functional Oral Intake Scale (FOIS) is a scale that shows the functional oral intake of patients with dysphagia. FOIS used for evaluation is a two part scale consisting of 7 levels. It is used to show whether the individual is dependent on the feeding tube and the level of oral intake. On this scale, 7 shows the best and 1 shows the worst functional oral intake. The change in FOIS will be our primary outcome measure in our research. It has been evaluated as an appropriate tool to demonstrate the change in functional oral intake in stroke patients. It is suitable as an independent measure of functional oral intake in prospective studies of stroke-related dysphagia.

    Measured: before intervention, immediately after intervention, 3 months after the intervention

Secondary outcomes (6)
  1. Change in Eating Assessment Tool-10 (EAT-10) Score

    Eating Assessment Tool-10 (EAT-10) is used to assess participants' dysphagia symptoms, symptom severity, and risk of oropharyngeal dysphagia. This scale is a scale of 10 questions that the patient himself answers, which questions the symptoms of dysphagia. The answer points for each question range from 0 (no problem) to 4 (serious problem). If EAT-10 score is ≥3, it is considered as "risk of oropharyngeal dysphagia". It is a useful tool to evaluate the severity of dysphagia symptom in the clinic, to monitor the progression and effectiveness of the disease.

    Measured: before intervention, immediately after intervention, 3 months after the intervention

  2. Change in Swallowing-related Quality of Life (SWAL-QOL) Score

    Swallowing-related quality of life scale (SWAL-QOL) is used to evaluate the effect of swallowing disorders on quality of life. It was created to evaluate the quality of life of patients with oropharyngeal dysphagia. It includes a total of 44 questions under eating disorder, eating time, eating desire, food selection, communication, anxiety, mental health, social functionality, fatigue, and sleep subgroups. Each question is evaluated with a score ranging from 1 (worst) to 5 (best). The subgroup scores of the scale and the total score of the scale can be used to assess the change in patients.

    Measured: before intervention, immediately after intervention, 3 months after the intervention

  3. Change in Visual Analog Scale (VAS)

    Patients' difficulty in swallowing will be questioned using the Visual Analogue Scale (VAS). On a scale of ten centimeters, patients will be asked to mark the appropriate level of dysphagia 0: No dysphagia, 10: Very severe dysphagia.

    Measured: before intervention, immediately after intervention, 3 months after the intervention

  4. Change in Laryngostroboscopy Examination

    In the Istanbul Faculty of Medicine Otorhinolaryngology Diseases Clinic, evaluations will be made by the Ear Nose Throat Specialist. Whether there is vocal cord paresis and paralysis and whether glottic patency is evaluated in the laryngostroboscopic examination.

    Measured: before intervention, immediately after intervention

  5. Change in Fiberoptic Endoscopic Evaluation of Swallowing (FEES)

    Fiberoptic endoscopic swallowing assessment will be performed by the otolaryngologist doctor before and immediately after the treatment. In the fiberoptic endoscopic swallowing assessment, the condition of the patient according to the penetration aspiration scale will be checked. Grade 1 represents the best and grade 7 the worst on the penetration aspiration scale.

    Measured: before intervention, immediately after intervention

  6. Change in Voice-Related Quality of Life (V-RQOL) Score

    This ten-item scale is a scale designed for adult populations with voice disorders to measure both social-emotional and physical-functional aspects of voice problems. The answer points for each question range from 1 (few problems) to 5 (serious problems). A total score change on this scale will be used to evaluate patients.

    Measured: before intervention, immediately after intervention, 3 months after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2020
  2. Study start15 Apr 2020
  3. Primary completion30 Jan 2022
  4. Study completion16 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04421937
Sponsor's protocol ID
Istanbul University, Istanbul
Status last verified
Aug 2022
First submitted
16 May 2020
Last updated
23 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Procedure: Traditional Dysphagia Therapy (TDT) and Procedure: Neuromuscular Electrical Stimulation with TDT in people with Stroke and Swallowing Disorder, run by Istanbul University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Functional Oral Intake Scale (FOIS) (time frame: before intervention, immediately after intervention, 3 months after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in